OBJECTIVES: The aims of the study were to investigate the relationship between sarcopenia and renin-angiotensin system-related disorders and to explore the effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on muscle mass/function and physical performance. DESIGN: This multicenter, cross-sectional study was performed using ISarcoPRM algorithm for the diagnosis of sarcopenia. RESULTS: Of the 2613 participants (mean age = 61.0 ± 9.5 yrs), 1775 (67.9%) were hypertensive. All sarcopenia-related parameters (except chair stand test in males) were worse in hypertensive group than in normotensive group (all P < 0.05). When clinical/potential confounders were adjusted, hypertension was found to be an independent predictor of sarcopenia in males (odds ratio = 2.403 [95% confidence interval = 1.514-3.813]) and females (odds ratio = 1.906 [95% confidence interval = 1.328-2.734], both P < 0.001). After adjusting for confounding factors, we found that all sarcopenia-related parameters (except grip strength and chair stand test in males) were independently/negatively related to hypertension (all P < 0.05). In females, angiotensin-converting enzyme inhibitors users had higher grip strength and chair stand test performance values but had lower anterior thigh muscle thickness and gait speed values, as compared with those using angiotensin II receptor blockers (all P < 0.05). CONCLUSIONS: Hypertension was associated with increased risk of sarcopenia at least 2 times. Among antihypertensives, while angiotensin-converting enzyme inhibitors had higher muscle function values, angiotensin II receptor blockers had higher muscle mass and physical performance values only in females.

From the Department of Physical and Rehabilitation Medicine Hacettepe University Medical School Ankara Turkey

See more in PubMed

Kara M, Kaymak B, Frontera W, et al.: Diagnosing sarcopenia: functional perspectives and a new algorithm from the ISarcoPRM. J Rehabil Med 2021;53:jrm00209

Pacifico J, Geerlings MAJ, Reijnierse EM, et al.: Prevalence of sarcopenia as a comorbid disease: a systematic review and meta-analysis. Exp Gerontol 2020;131:110801

Reginster JY, Cooper C, Rizzoli R, et al.: Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia. Aging Clin Exp Res 2016;28:47–58

Ekiz T, Kara M, Ata AM, et al.: Rewinding sarcopenia: a narrative review on the renin-angiotensin system. Aging Clin Exp Res 2021;33:2379–92

Bloemberg D, McDonald E, Dulay D, et al.: Autophagy is altered in skeletal and cardiac muscle of spontaneously hypertensive rats. Acta Physiol (Oxf) 2014;210:381–91

Cabello-Verrugio C, Morales MG, Rivera JC, et al.: Renin-angiotensin system: an old player with novel functions in skeletal muscle. Med Res Rev 2015;35:437–63

Ata AM, Kara M, Ekiz T, et al.: Reassessing sarcopenia in hypertension: STAR and ACE inhibitors excel. Int J Clin Pract 2021;75:e13800

Onder G, Penninx BW, Balkrishnan R, et al.: Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet 2002;359:926–30

Di Bari M, van de Poll-Franse LV, Onder G, et al.: Antihypertensive medications and differences in muscle mass in older persons: the Health, Aging and Body Composition Study. J Am Geriatr Soc 2004;52:961–6

Anker SD, Morley JE, von Haehling S: Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle 2016;7:512–4

Cruz-Jentoft AJ, Sayer AA: Sarcopenia. Lancet 2019;393:2636–46

Kara M, Frontera WR, Özçakar L: Measure what matters most in sarcopenia: regional vs. appendicular muscle mass? J Am Med Dir Assoc 2021;22:883–4

Tsukasaki K, Matsui Y, Arai H, et al.: Association of muscle strength and gait speed with cross-sectional muscle area determined by mid-thigh computed tomography—a comparison with skeletal muscle as measured by dual-energy x-ray absorptiometry. J Frailty Aging 2020;9:82–9

Kara M, Kaymak B, Ata AM, et al.: STAR-Sonographic Thigh Adjustment Ratio: A golden formula for the diagnosis of sarcopenia. Am J Phys Med Rehabil 2020;99:902–8

Bai T, Fang F, Li F, et al.: Sarcopenia is associated with hypertension in older adults: a systematic review and meta-analysis. BMC Geriatr 2020;20:279

Santhanam P, Sarkar S, Ahima RS: Relationship between lean body mass indices, physical activity, and systolic BP: analysis of 1999–2006 NHANES data. J Clin Hypertens (Greenwich) 2019;21:692–3

Han K, Park YM, Kwon HS, et al.: Sarcopenia as a determinant of blood pressure in older Koreans: findings from the Korea National Health and Nutrition Examination Surveys (KNHANES) 2008–2010. PLoS One 2014;9:e86902

Han JM, Lee MY, Lee K-B, et al.: Low relative skeletal muscle mass predicts incident hypertension in Korean men: a prospective cohort study. J Hypertens 2020;38:2223–9

Cabello-Verrugio C, Rivera JC, Garcia D: Skeletal muscle wasting: new role of nonclassical renin-angiotensin system. Curr Opin Clin Nutr Metab Care 2017;20:158–63

Castillo-Olea C, Garcia-Zapirain Soto B, Zuñiga C: Evaluation of prevalence of the sarcopenia level using machine learning techniques: case study in Tijuana Baja California, Mexico. Int J Environ Res Public Health 2020;17:1917

Hurst C, Murray JC, Granic A, et al.: Long-term conditions, multimorbidity, lifestyle factors and change in grip strength over 9 years of follow-up: findings from 44,315 UK biobank participants. Age Ageing 2021;50:2222–9

Stenholm S, Tiainen K, Rantanen T, et al.: Long-term determinants of muscle strength decline: prospective evidence from the 22-year mini-Finland follow-up survey. J Am Geriatr Soc 2012;60:77–85

Rantanen T, Masaki K, Det F, et al.: Grip strength changes over 27 yr in Japanese-American men. J Appl Physiol ( 1985 ) 1998;85:2047–53

Kara M, Ata AM, Kaymak B, et al.: Comment on Asian Working Group on Sarcopenia's Updated Consensus Recommendations: emphasis on anterior thigh muscle mass. J Am Med Dir Assoc 2020;21:1173–4

Kara M, Ata AM, Kaymak B, et al.: Ultrasound imaging and rehabilitation of muscle disorders: part 2: nontraumatic conditions. Am J Phys Med Rehabil 2020;99:636–44

Ata AM, Kara M, Kaymak B, et al.: Regional and total muscle mass, muscle strength and physical performance: the potential use of ultrasound imaging for sarcopenia. Arch Gerontol Geriatr 2019;83:55–60

Özçakar L, Ata AM, Kaymak B, et al.: Ultrasound imaging for sarcopenia, spasticity and painful muscle syndromes. Curr Opin Support Palliat Care 2018;12:373–81

Dodds RM, Murray JC, Granic A, et al.: Prevalence and factors associated with poor performance in the 5-chair stand test: findings from the Cognitive Function and Ageing Study II and proposed Newcastle protocol for use in the assessment of sarcopenia. J Cachexia Sarcopenia Muscle 2021;12:308–18

Baune BT, Schmidt WP, Roesler A, et al.: Functional consequences of subcortical white matter lesions and MRI-defined brain infarct in an elderly general population. J Geriatr Psychiatry Neurol 2009;22:266–73

Fonseca Alves DJ, Bartholomeu-Neto J, Júnior ER, et al.: Walking speed, risk factors, and cardiovascular events in older adults-systematic review. J Strength Cond Res 2017;31:3235–44

Dumurgier J, Elbaz A, Dufouil C, et al.: Hypertension and lower walking speed in the elderly: the Three-City study. J Hypertens 2010;28:1506–14

Vaz Fragoso CA, McAvay GJ: Antihypertensive medications and physical function in older persons. Exp Gerontol 2020;138:111009